Santa Ana Bio, Inc. — Form D
Santa Ana Bio, Inc. of Alameda, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-01. The offering totals $42.0M, of which $8.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-06-01
- Form: D
- Accession: 0001864492-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $42.0M
- Amount sold: $8.0M
- Remaining: $34.0M
- Investors: 1
- Date of first sale: 2021-05-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-401289
Issuer
- Name: Santa Ana Bio, Inc.
- CIK: 0001864492
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1105 Atlantic Ave., Alameda, CA, 94501
- Phone: (858) 705-2660
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Jerel Davis | Executive Officer | Alameda, CA |
| Mittie Doyle | Director | Alameda, CA |
| Peter Emtage | Director | Alameda, CA |
| Peter Emtage | Executive Officer | Alameda, CA |
| Jerel Davis | Director | Alameda, CA |
| Shinichiro Fuse | Director | Alameda, CA |
| Brendan Bulik-Sullivan | Director | Alameda, CA |
| Christine Borowski | Director | Alameda, CA |
| Marcelo Bigalo | Director | Alameda, CA |
| Thomas Woiwode | Director | San Francisco, CA |
Other filings by this issuer (2)
More